After diabetic retinopathy, the varieties of retinal vein
occlusion constitute the most prevalent category of retinal
vascular disease. For macular edema associated with central
retinal vein occlusion (CRVO), no effective therapy existed until
2009, despite decades of research and failed pilot therapies.
This comprehensive, illustrated text integrates recent advances
in treatments with the parallel progress in understanding of